{
  "synthesized_claims": [
    {
      "statement": "Cytoprotective CBD (EC50 2-3.7 \u03bcM via TRPV1/2) dominates daytime (hyperpolarized \u03c8 closes VDAC1, blocking cytotoxicity); nighttime flip via open VDAC1.",
      "mechanism": "Low-dose CBD modulates Ca2+/metabolite flux protectively; VDAC1 closure at -180 mV requires >Kd CBD for forced oligomerization.",
      "falsifiable_by": "TRPV1/2 KO cells show no daytime protection but retain nighttime cytotoxicity shift.",
      "type": 1,
      "confidence": 0.695,
      "overlap_count": 3,
      "models": [
        "gemini",
        "grok",
        "mistral"
      ],
      "tuples": "frozenset({('cbd', 'modulates', 'vdac1')})",
      "chunk_text": "Cytoprotective CBD (EC50 2-3.7 \u03bcM via TRPV1/2) dominates daytime (hyperpolarized \u03c8 closes VDAC1, blocking cytotoxicity); nighttime flip via open VDAC1."
    },
    {
      "statement": "Circadian depolarized \u0394\u03a8m (-165 mV nighttime) lowers CBD cytotoxic IC50 3-5x (to 3-5 \u03bcM from 15 \u03bcM daytime), enabling sub-Kd (11 \u03bcM) toxicity via VDAC1.",
      "mechanism": "Depolarized \u0394\u03a8m favors VDAC1 open state (P_open >80%), enhancing CBD binding cooperativity (Hill n>1.5) and oligomerization for cyt c release.",
      "falsifiable_by": "Circadian-synchronized cells show no IC50 shift (MTT/LDH assay) when \u0394\u03a8m clamped (oligomycin/FCCP) at peaks/troughs.",
      "type": 1,
      "confidence": 0.673,
      "overlap_count": 3,
      "models": [
        "gemini",
        "grok",
        "mistral"
      ],
      "tuples": "frozenset({('ic50', 'interacts', 'vdac1'), ('cbd', 'interacts', 'ic50')})",
      "chunk_text": "Circadian depolarized \u0394\u03a8m (-165 mV nighttime) lowers CBD cytotoxic IC50 3-5x (to 3-5 \u03bcM from 15 \u03bcM daytime), enabling sub-Kd (11 \u03bcM) toxicity via VDAC1."
    },
    {
      "statement": "3:** The cytotoxic transition occurs NOT at depolarized \u0394\u03a8m but at **hyperpolarized** \u0394\u03a8m (~-180 mV), where VDAC1 partial closure promotes oligomerization; CBD at \u22655 \u03bcM stabilizes closed-state oligomeric pores, enabling cytochrome c release. The established consensus (depolarized = toxic) may be inverted.",
      "mechanism": "Closed VDAC1 exposes oligomerization interfaces (\u03b2-strands 1,2,19); CBD's hydrophobic intercalation between monomers stabilizes hexameric pores large enough for cytochrome c (~12 kDa) passage.",
      "falsifiable_by": "CBD dose-response curves for apoptosis in cells with \u0394\u03a8m clamped to -150 mV vs. -180 mV using ionophores; if cytotoxicity is higher at -180 mV, this claim holds.",
      "type": 2,
      "confidence": 0.5,
      "overlap_count": 2,
      "models": [
        "claude",
        "grok"
      ],
      "tuples": "frozenset({('cbd', 'upregulates', 'vdac1')})",
      "chunk_text": "3:** The cytotoxic transition occurs NOT at depolarized \u0394\u03a8m but at **hyperpolarized** \u0394\u03a8m (~-180 mV), where VDAC1 partial closure promotes oligomerization; CBD at \u22655 \u03bcM stabilizes closed-state oligomeric pores, enabling cytochrome c release. The established consensus (depolarized = toxic) may be inverted."
    },
    {
      "statement": "VDAC1 P_open >80% at depolarized \u0394\u03a8m (>-160 mV) vs <30% at hyperpolarized (<-170 mV), validating grok singular, rejecting mistral inversion.",
      "mechanism": "\u0394\u03a8m influences OMM voltage via Donnan equilibrium; depolarization reduces |OMM V|, preventing N-terminal helix pore block (claude singular overlap).",
      "falsifiable_by": "Proteoliposome patch-clamp of VDAC1 under mimicked \u0394\u03a8m (-150 vs -180 mV) shows inverted P_open.",
      "type": 3,
      "confidence": 0.81,
      "overlap_count": 1,
      "models": [
        "grok"
      ],
      "tuples": "frozenset({('vdac1', 'interacts', 'omm')})",
      "chunk_text": "VDAC1 P_open >80% at depolarized \u0394\u03a8m (>-160 mV) vs <30% at hyperpolarized (<-170 mV), validating grok singular, rejecting mistral inversion."
    },
    {
      "statement": "1:** Circadian \u0394\u03a8m oscillates with amplitude ~15-20 mV (trough ~-160 to -165 mV during late rest phase, peak ~-180 mV during active phase), driven by clock-controlled expression of ETC complex subunits and UCP2/3.",
      "mechanism": "BMAL1/CLOCK drive rhythmic transcription of NAMPT\u2192NAD+ cycling, which modulates Complex I activity and proton pumping efficiency.",
      "falsifiable_by": "TMRM/JC-1 live imaging of \u0394\u03a8m across 24h in SCN-synchronized cells with and without BMAL1 knockout.",
      "type": 3,
      "confidence": 0.6,
      "overlap_count": 1,
      "models": [
        "claude"
      ],
      "tuples": "frozenset({('ucp2', 'interacts', 'bmal1'), ('nampt', 'interacts', 'nad'), ('bmal1', 'interacts', 'clock'), ('etc', 'interacts', 'ucp2'), ('clock', 'interacts', 'nampt')})",
      "chunk_text": "1:** Circadian \u0394\u03a8m oscillates with amplitude ~15-20 mV (trough ~-160 to -165 mV during late rest phase, peak ~-180 mV during active phase), driven by clock-controlled expression of ETC complex subunits and UCP2/3."
    },
    {
      "statement": "2:** VDAC1 gating responds to OMM voltage (not \u0394\u03a8m directly); at depolarized \u0394\u03a8m (~-160 mV), reduced Donnan potential across IMS keeps VDAC1 in high-conductance open state, where CBD binds the open pore without inducing oligomerization\u2014this is the cytoprotective regime.",
      "mechanism": "Open VDAC1 permits CBD to modulate metabolite flux (enhancing ATP/ADP exchange) without the conformational strain that closed-state dimers/oligomers impose.",
      "falsifiable_by": "Electrophysiology of reconstituted VDAC1 \u00b1 CBD at controlled voltages, measuring single-channel conductance and oligomer crosslinking simultaneously.",
      "type": 3,
      "confidence": 0.55,
      "overlap_count": 1,
      "models": [
        "claude"
      ],
      "tuples": "frozenset({('atp', 'modulates', 'cbd'), ('cbd', 'interacts', 'vdac1'), ('cbd', 'upregulates', 'vdac1')})",
      "chunk_text": "2:** VDAC1 gating responds to OMM voltage (not \u0394\u03a8m directly); at depolarized \u0394\u03a8m (~-160 mV), reduced Donnan potential across IMS keeps VDAC1 in high-conductance open state, where CBD binds the open pore without inducing oligomerization\u2014this is the cytoprotective regime."
    },
    {
      "statement": "2**: VDAC1\u2019s open probability peaks at **-170 mV** and declines linearly to **50% at -150 mV**, with closure promoting oligomerization. **TYPE**: 2 (novel prediction) **CONFIDENCE**: 0.6 **MECHANISM**: The N-terminal \u03b1-helix of VDAC1 acts as a voltage sensor, blocking the pore at depolarized potentials (consistent with *mistral*\u2019s singular claim). **FALSIFIABLE BY**: Patch-clamp recordings of VDAC1 in proteoliposomes at -140 mV vs. -180 mV, or cryo-EM structures under these conditions.",
      "mechanism": ": The N-terminal \u03b1-helix of VDAC1 acts as a voltage sensor, blocking the pore at depolarized potentials (consistent with *mistral*\u2019s singular claim).",
      "falsifiable_by": ": Patch-clamp recordings of VDAC1 in proteoliposomes at -140 mV vs. -180 mV, or cryo-EM structures under these conditions.",
      "type": 3,
      "confidence": 0.5,
      "overlap_count": 1,
      "models": [
        "mistral"
      ],
      "tuples": "frozenset({('falsifiable', 'downregulates', 'vdac1'), ('type', 'upregulates', 'vdac1')})",
      "chunk_text": "2**: VDAC1\u2019s open probability peaks at **-170 mV** and declines linearly to **50% at -150 mV**, with closure promoting oligomerization. **TYPE**: 2 (novel prediction) **CONFIDENCE**: 0.6 **MECHANISM**: The N-terminal \u03b1-helix of VDAC1 acts as a voltage sensor, blocking the pore at depolarized potentials (consistent with *mistral*\u2019s singular claim). **FALSIFIABLE BY**: Patch-clamp recordings of VDAC1 in proteoliposomes at -140 mV vs. -180 mV, or cryo-EM structures under these conditions."
    },
    {
      "statement": "4**: The outer mitochondrial membrane (OMM) voltage\u2014modulated by \u0394\u03a8m via Donnan equilibrium\u2014directly gates VDAC1, with depolarized \u0394\u03a8m reducing OMM voltage and favoring VDAC1\u2019s open state. **TYPE**: 2 (mechanistic refinement) **CONFIDENCE**: 0.55 **MECHANISM**: \u0394\u03a8m depolarization decreases the intermembrane space potential, lowering OMM voltage and stabilizing VDAC1\u2019s anion-permeable open conformation. **FALSIFIABLE BY**: Simultaneous measurements of \u0394\u03a8m (TMRM) and OMM voltage (OMM-targeted voltage sensors) in cells under circadian \u0394\u03a8m cycling. ---",
      "mechanism": ": \u0394\u03a8m depolarization decreases the intermembrane space potential, lowering OMM voltage and stabilizing VDAC1\u2019s anion-permeable open conformation.",
      "falsifiable_by": ": Simultaneous measurements of \u0394\u03a8m (TMRM) and OMM voltage (OMM-targeted voltage sensors) in cells under circadian \u0394\u03a8m cycling. --- **",
      "type": 3,
      "confidence": 0.5,
      "overlap_count": 1,
      "models": [
        "mistral"
      ],
      "tuples": "frozenset({('mechanism', 'downregulates', 'omm'), ('omm', 'downregulates', 'vdac1')})",
      "chunk_text": "4**: The outer mitochondrial membrane (OMM) voltage\u2014modulated by \u0394\u03a8m via Donnan equilibrium\u2014directly gates VDAC1, with depolarized \u0394\u03a8m reducing OMM voltage and favoring VDAC1\u2019s open state. **TYPE**: 2 (mechanistic refinement) **CONFIDENCE**: 0.55 **MECHANISM**: \u0394\u03a8m depolarization decreases the intermembrane space potential, lowering OMM voltage and stabilizing VDAC1\u2019s anion-permeable open conformation. **FALSIFIABLE BY**: Simultaneous measurements of \u0394\u03a8m (TMRM) and OMM voltage (OMM-targeted volt"
    },
    {
      "statement": "The",
      "mechanism": "",
      "falsifiable_by": "",
      "type": 3,
      "confidence": 0.5,
      "overlap_count": 1,
      "models": [
        "deepseek"
      ],
      "tuples": "frozenset()",
      "chunk_text": "The"
    },
    {
      "statement": "4:** Circadian hexokinase-II dissociation from VDAC1 (regulated by GSK3\u03b2/AKT cycling) is the dominant modulator of CBD's therapeutic window, more than \u0394\u03a8m per se.",
      "mechanism": "HK-II binding occludes CBD's VDAC1 binding site; circadian AKT activity peaks drive HK-II association, creating a time window where CBD cannot access VDAC1.",
      "falsifiable_by": "CBD-VDAC1 FRET signal \u00b1 HK-II overexpression across circadian timepoints. \u2500\u2500\u2500",
      "type": 3,
      "confidence": 0.35,
      "overlap_count": 1,
      "models": [
        "claude"
      ],
      "tuples": "frozenset({('akt', 'interacts', 'vdac1'), ('cbd', 'interacts', 'hk')})",
      "chunk_text": "4:** Circadian hexokinase-II dissociation from VDAC1 (regulated by GSK3\u03b2/AKT cycling) is the dominant modulator of CBD's therapeutic window, more than \u0394\u03a8m per se."
    }
  ],
  "conflicts": [],
  "total_rounds": 0,
  "snapshots": [
    {
      "round_num": 0,
      "jaccard": 0.05125639772341315,
      "cosine": 0.4728844383731484,
      "jsd": 0.16259219523942603,
      "kappa": 0.8921773142112125,
      "type_distribution": {
        "0": 0.0,
        "1": 0.125,
        "2": 0.6875,
        "3": 0.1875
      },
      "type_01_ratio": 0.125,
      "n_claims_per_model": [
        4,
        4,
        4,
        3,
        1
      ]
    },
    {
      "round_num": 1,
      "jaccard": 0.1474468181550206,
      "cosine": 0.48376155868172643,
      "jsd": 0.3128665757891141,
      "kappa": 0.7931034482758621,
      "type_distribution": {
        "0": 0.0,
        "1": 0.4,
        "2": 0.13333333333333333,
        "3": 0.4666666666666667
      },
      "type_01_ratio": 0.4,
      "n_claims_per_model": [
        4,
        4,
        4,
        2,
        1
      ]
    }
  ]
}